Menstrual Migraine: Why It Is The Drop In Estrogen, Not The Level

It arrives on day one or the day before, with a reliability nothing else in your life matches. It lasts longer than your other migraines, responds less well to whatever normally works, and comes back after you thought it had gone.

Menstrual migraine is not simply a migraine that happens to fall near your period. It is a distinct pattern with a specific hormonal trigger, and — critically — it is triggered by a drop in estrogen rather than by a level. Once that clicks, both why it happens and why perimenopause makes it worse become obvious.

Withdrawal, not level

Estrogen rises through the follicular phase, peaks around ovulation, and falls sharply in the last days of the luteal phase before menstruation. That late-luteal fall is the trigger.

Estrogen influences serotonin systems and CGRP — calcitonin gene-related peptide, the neuropeptide central to migraine and the target of the newer preventive drugs. When estrogen drops rapidly, those systems destabilise.

Three things follow that explain the pattern.

It is the rate of fall that matters, not how low you go. A steep drop provokes an attack; a stable low level does not. This is why some women’s migraines improve dramatically after menopause, once the fluctuation stops — but often worsen considerably during perimenopause, when fluctuation is at its most violent.

Attacks cluster at two points, not one. The late-luteal drop is the main one. A second, smaller drop occurs just after the ovulatory peak, which is why some women get a mid-cycle attack they never connect to hormones.

Pure menstrual migraine attacks are typically without aura, even in women who get aura at other times. Worth knowing, because aura status changes contraceptive decisions.

Why these attacks are harder to treat

Menstrual attacks are, on average, longer, more severe, more likely to recur after initial relief, and less responsive to acute treatment than the same woman’s non-menstrual attacks. This is documented, not a matter of perception, and it is worth knowing because women frequently conclude their medication has stopped working when the pattern is specific to these attacks.

Prostaglandins add a second layer: they are elevated during menstruation, they contribute to migraine, and they are why the same days bring cramps. That overlap is also why NSAIDs have a dual role here.

Establishing your pattern first

Everything downstream depends on knowing your timing, and the timing is more precise than most women assume.

Track for three cycles: day of cycle, attack start and end, severity, and what you took. The definition used clinically is attacks occurring between two days before bleeding starts and three days after, in at least two of three cycles.

If your attacks land in that window consistently, you can treat them preventively rather than reactively — which is the single biggest change available, because it converts an unpredictable emergency into a scheduled intervention.

Short-term prevention

This is the approach that most changes outcomes and it is underused.

NSAIDs started before the attack. Naproxen begun one to two days before your expected attack and continued through the vulnerable window has evidence for menstrual migraine and addresses the prostaglandin component simultaneously. Discuss dosing with your doctor.

Triptans as short-term prophylaxis. Frovatriptan in particular, with its long half-life, has evidence for perimenstrual prevention taken twice daily across a six-day window. This is a recognised use, not off-label improvisation, and many women have never been offered it.

Magnesium. Reasonable evidence in migraine generally, with some specifically for menstrual migraine, typically at 400-600mg daily of a well-absorbed form. Some protocols start it around day 15 and continue through menstruation. Low cost, low risk, worth trying.

Estrogen stabilisation. Since the trigger is the drop, smoothing it can prevent attacks — for example transdermal estradiol across the perimenstrual window. Effective for some women, and it requires a doctor because it interacts with the aura and stroke-risk question below.

Acute treatment, done properly

Treat early. Triptans work best taken at the first sign. Once an attack is established, central sensitisation makes it substantially harder to abort — and the common instinct to wait and see whether it develops is what makes these attacks worse.

Consider recurrence in advance. Menstrual attacks recur more often, so a longer-acting triptan, or a triptan combined with an NSAID, may suit better than a short-acting one alone.

Watch medication overuse. Treating on more than ten days a month with triptans or combination analgesics, or fifteen with simple analgesics, can produce medication overuse headache. Women with frequent menstrual attacks are at real risk of drifting into this, and it is a common reason a previously effective drug stops working.

The aura and contraception issue

This matters more than anything else in the article.

Migraine with aura is associated with increased ischaemic stroke risk, and combined hormonal contraception increases it further. Guidance in most countries advises against combined oral contraceptives in women with migraine with aura, at any age.

Migraine without aura is treated differently, and continuous or extended-cycle combined contraception is sometimes used deliberately to avoid the estrogen withdrawal that triggers attacks.

So: know whether you get aura, and tell your doctor explicitly. Aura is the visual or sensory disturbance preceding the headache — zigzag lines, blind spots, tingling spreading up an arm — developing over five to twenty minutes and lasting under an hour. It is not the same as light sensitivity during the headache, which is a very common confusion and points people to the wrong answer.

What perimenopause does to all of this

Frequently the worst period of a woman’s migraine history, and for a mechanical reason: perimenopause is defined by erratic estrogen. More fluctuation means more withdrawal events means more attacks. Cycles also become unpredictable, so the tracking that made short-term prevention possible stops working.

The encouraging part is that this phase ends. Migraine frequently improves substantially after menopause once estrogen settles at a stable low. If you are in the worst of it at 46, that is not a permanent trajectory.

The transition also brings sleep fragmentation, and poor sleep is an independent migraine trigger — which is why the mechanisms behind waking at three in the morning are worth addressing as part of migraine management rather than as a separate complaint.

On supplements, the order of operations here matters more than usual because effective medical options exist and are underprescribed. Magnesium has the best evidence of anything available over the counter and is worth trying on its own merits. Riboflavin at 400mg daily has some support. Beyond those, a broader hormonal formula is not a migraine treatment and should not be presented as one — where it has any rationale is the adjacent picture, the perimenopausal instability that is driving the increase in attacks. MenoRescue is the one we looked at in that space. If you are getting attacks every cycle and have never been offered short-term prophylaxis, that conversation with your doctor is worth far more than anything on this page. Affiliate link; we may earn a commission at no extra cost to you.

The short version

Menstrual migraine is triggered by estrogen falling, not by estrogen being high or low — which is why the rate of change matters and why perimenopause is often the worst phase. These attacks are longer, more severe and more prone to recurrence than your other ones, so they need a different approach: track three cycles, then treat preventively across the window rather than reactively once it starts. NSAIDs, frovatriptan and magnesium all have evidence in short-term prophylaxis and most women have never been offered any of them. And if you get aura, say so before anyone prescribes combined hormonal contraception.